Researchers at Daping Hospital in China have reported that liver-targeted delivery of the APOE3-Christchurch (APOE3Ch) variant, a rare protective form of apolipoprotein E, can indirectly reduce brain pathology, highlighting the therapeutic potential of peripheral approaches to Alzheimer’s disease.
Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Armata, Atara, Bright Uro, Microsure, Partner, Repertoire.
Biopharma and med-tech happenings, including deals and partnerships, and other news in brief: Bioora, GSK, Halozyme, Novartis, Novo Nordisk, Oragenics, Signy, Wellington Zhaotai.
Clinical updates for biopharma and med tech, including data readouts and publications: Aim, ALX, Bayer, Cardiol, Delphi, Engene, Entrada, Incyte, Rapid Medical, Totus.
RSS
